PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage
出版年份 2010 全文链接
标题
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage
作者
关键词
-
出版物
LABORATORY INVESTIGATION
Volume 90, Issue 10, Pages 1517-1532
出版商
Springer Nature
发表日期
2010-06-07
DOI
10.1038/labinvest.2010.111
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- How safe is the use of thiazolidinediones in clinical practice?
- (2009) CV Rizos et al. Expert Opinion On Drug Safety
- Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation
- (2009) Craig L. Maynard et al. IMMUNOLOGICAL REVIEWS
- Rosiglitazone and PPAR-γ overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins
- (2009) Jui-Sheng Wu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cyclooxygenase-2 Mediates Dialysate-Induced Alterations of the Peritoneal Membrane
- (2009) L. S. Aroeira et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus
- (2009) J. E. Toblli et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation
- (2009) Yusheng Ren et al. VASCULAR PHARMACOLOGY
- Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor γ synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells
- (2008) Wei-Hao Sun et al. CANCER LETTERS
- Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF- B/Snail1 pathway
- (2008) R. Strippoli et al. Disease Models & Mechanisms
- The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
- (2008) Su-Yen Goh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients
- (2008) P. Aramwit et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport
- (2008) G. del Peso et al. KIDNEY INTERNATIONAL
- PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
- (2008) Toru Kawai et al. LABORATORY INVESTIGATION
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats
- (2008) I. Hirahara et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
- (2008) G. J. Ko et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca2+ in opossum kidney cells
- (2008) Chae Hwa Kwon et al. TOXICOLOGY
- Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells
- (2007) Chae Hwa Kwon et al. TOXICOLOGY
- Amadori adducts activate nuclear factor-κB-related proinflammatory genes in cultured human peritoneal mesothelial cells
- (2005) Julián Nevado et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started